Functional effects of 17alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro
<p>Abstract</p> <p>Background</p> <p>17alpha-hydroxyprogesterone caproate (17P) administration reportedly improves outcome for women with a previous spontaneous preterm delivery. This study, using in vitro strips of human uterine smooth muscle, aimed to investigate the...
Main Authors: | Morrison John J, Friel Anne M, O'Reilly Michael W, Sexton Donal J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-12-01
|
Series: | Reproductive Biology and Endocrinology |
Online Access: | http://www.rbej.com/content/2/1/80 |
Similar Items
-
The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use
by: Carla E. Ransom, et al.
Published: (2011-01-01) -
Patient and Provider Perspectives on Acceptability, Access, and Adherence to 17-Alpha-Hydroxyprogesterone Caproate for Preterm Birth Prevention
Published: (2021-07-01) -
Maternal Characteristics Influencing the Development of Gestational Diabetes in Obese Women Receiving 17-alpha-Hydroxyprogesterone Caproate
by: Robert Egerman, et al.
Published: (2014-01-01) -
Effect of 17 α-Hydroxyprogesterone Caproate on the Prevention of Preterm Labor: A Randomized Controlled Trial Study
by: Hamed Jafarpour, et al.
Published: (2020-07-01) -
Understanding barriers to utilization of 17-hydroxyprogesterone caproate and other interventions to prevent preterm birth in Fresno County, California
by: Subhashini Ladella, et al.
Published: (2021-08-01)